Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|March 1, 1994
Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria?J T Sahlroot, G W PledgerEpilepsia|January 1, 1992
Pharmacokinetic and dose tolerability study of ADD 94057 in comedicated patients with partial seizuresG W Pledger, K D Laxer, J T Sahlroot, et al.Biopharmaceutics & Drug Disposition|March 1, 1997
A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax)I Mahmood, J T SahlrootEpilepsy Research. Supplement|January 1, 1988
Compliance in clinical trials: impact on design, analysis and interpretationG W PledgerJournal of Biopharmaceutical Statistics|September 1, 1993
Confidence intervals versus p-values for interpretation of clinical trial results: introductionG W PledgerNeurology|October 1, 1994
Flunarizine for treatment of partial seizures: results of a concentration-controlled trialG W Pledger, J C Sackellares, D M Treiman, et al.Neurology|August 1, 1994
Dezinamide for partial seizures: results of an n-of-1 design trialM D Privitera, D M Treiman, G W Pledger, et al.Drugs|October 1, 1994
Evaluation of antiepileptic drug efficacy. A review of clinical trial designG W Pledger, D SchmidtControlled Clinical Trials|December 1, 1991
Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentrationG W Pledger, D M TreimanEpilepsia|September 1, 1991
Clinical trials of investigational antiepileptic drugs: monotherapy designsG W Pledger, L D KramerPageof 2